BNET Industries

Omrix Biopharmaceuticals Inc.

(OMRI) is in the Pharma Industry

Last Fiscal Year Sales:$61.7M
  • Public
  • US
Dow Jones Description

Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix' biosurgery product line includes products and product candidates that are used for the control of bleeding, or hemostasis, and other surgical applications. The Company's passive immunotherapy product line includes antibody-rich products and product candidates for the treatment of immune deficiencies, infectious diseases and potential biodefense applications.

Number of Employees 212
Contact Information

630 Fifth Ave

New York, New York 10017

www.omrix.com

(212) 887-6500

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Company and People Notes: King Acquires Alpharma for $1.6 B; Wyeth Names Michael Kamarck President...

    8/26/09 - Merger / Acquisition - View Story

News & Analysis

omrix biopharmaceuticals inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Robert Taub CEO
Nissim Mashiach President
Sophie Hobbs Interim CFO
Harold Safferstein Vice President, Business Dev
Nanci Prado Vice President
Francesca DeMartino Director, IR
Ansbert Gadicke Director

Board of Directors

Name (plus bio) Position
Fredric D. Price Chairman of the Board of Directors
Larry Ellberger Chairman
Bernard Horowitz Board of Directors
Kevin Rakin Board of Directors
Pamela W. McNamara Board of Directors
Steven St. Peter Board of Directors

Organization Position Status
Omrix Biopharmaceuticals, Inc CEO Current
Omrix Biopharmaceuticals, Inc Board of Directors Current
Baxter Travenol Laboratories, Inc. Former
Monsanto Company Former
Baxter International Inc. Former
INSEAD M.B.A. Former
University of Antwerp B.A. In Languages Former

Organization Position Status
Omrix Biopharmaceuticals, Inc President Current
Omrix Biopharmaceuticals, Inc Coo & Executive Vice President Former
University of Manchester M.B.A. Former
Technion-Israel Institute of Technology Bachelor of Science, Chemical Engineering Former

Organization Position Status
Omrix Biopharmaceuticals, Inc Interim CFO Current

Organization Position Status
Omrix Biopharmaceuticals, Inc Vice President, Business Dev Current

Organization Position Status
Omrix Biopharmaceuticals, Inc Vice President Current

Organization Position Status
Omrix Biopharmaceuticals, Inc Director, IR Current

Fredric D. Price, 63 , has served as a member of our board of directors since March 2007. He is currently Executive Chairman of the Board of Directors of Peptimmune, Chairman of the Board of Directors of Omrix Biopharmaceuticals and a member of the board of directors of Enobia Pharma. Previously, he was Chairman of the Board of Directors and Chief Executive Officer of BioMarin Pharmaceutical from 2000 to 2004 and President, Chief Executive Officer and a member of the board of directors of Applied Microbiology from 1994 to 2000. As Chairman and/or CEO, he has raised $500 million in a variety of securities transactions, built FDA approved facilities and had drugs approved in the U.S. as well as in international markets. His earlier experience includes having been Vice President of Finance and Administration and Chief Financial Officer of Regeneron Pharmaceuticals, the founder of the strategy consulting firm RxFDP, and Vice President of Pfizer Pharmaceuticals with both line and staff responsibilities. Mr. Fredric Price is a co-inventor of 12 issued U.S. patents and one U.S. patent application. He received a B.A. from Dartmouth College and an M.B.A. from the Wharton School of the University of Pennsylvania.

Organization Position Status
Chiasma Inc. Acting CEO Current
Regeneron Pharmaceuticals, Inc. Vice President of Finance and Administration and Chief Financial Officer Current
Omrix Biopharmaceuticals, Inc Chairman of the Board of Directors Current
Pharmasset, Inc. Board of Directors Current
Enobia Pharma Inc Board of Directors Current
BioMarin Pharmaceutical Inc. Chief Executive Officer Former
Peptimmune, Inc. Executive Chairman of the Board of Directors Former
Pharmasset, Inc. Chairman, Omrix Biopharmaceuticals, New York, Ny Former
BioMarin Pharmaceutical Inc. Chairman of the Board of Directors Former
Omrix Biopharmaceuticals, Inc Board of Directors Former
The Wharton School of the University of Pennsylvania M.B.A. Former
Wharton Graduate School of the University of Pennsylvania M.B.A. Former
Dartmouth College B.A. Former

Mr. Ellberger became a Director of Celldex in August 2003. In October 2005, Mr. Ellberger was appointed interim Chief Executive Officer of PDI, Inc., where he had been serving as a Director and Chairman of the Audit Committee. Mr. Ellberger was a Board member and Senior VP of Powderject PLC from 1999-2003. Prior to joining Powderject, Mr. Ellberger was an officer of W.R. Grace & Co. from 1995 to 1999, serving as Interim Chief Executive Officer in 1997-1998, Chief Financial Officer from 1996 and Senior Vice President, Strategic Planning and Development from 1995. From 1975 to 1995, Mr. Ellberger held numerous senior executive positions at American Cyanamid Company, serving the last four years as Vice President, Corporate Development. In addition to his position at HVA, a healthcare transaction advisory firm, Mr. Ellberger is currently Chairman of the Board of Omrix Biopharmaceuticals, Inc. and is a Director of TransPharma Medical Ltd. and the Jewish Children’s Museum.

Organization Position Status
Omrix Biopharmaceuticals, Inc Chairman Current
PDI, Inc. Board of Directors Current
CELLDEX THERAPEUTICS, INC. Board of Directors Current
PDI, Inc. Interim CEO & Chief Admin Officer Former
W.R. Grace & Company CEO Former
PDI Inc. Interim Chief Executive Officer Former
CELLDEX THERAPEUTICS, INC. Interim Chief Executive Officer, Pdi, Inc. Former
W.R. Grace & Company Chief Financial Officer Former
PDI Inc. Chief Administrative Officer Former
PDI, Inc. Chief Administrative Officer Former
Powderject Pharmaceuticals, Plc Senior Vice President, Corporate Development Former
W.R. Grace & Company Senior Vice President, Strategic Planning and Development Former
CELLDEX THERAPEUTICS, INC. Vice President, Corporate Development Former
PDI Inc. Director and Chairman Former
American Cyanamid Company Senior Executive Former
Powderject Pharmaceuticals, Plc Board Member Former
Omrix Biopharmaceuticals, Inc Board of Directors Former
PDI, Inc. Director Former

Organization Position Status
MPM Capital Limited Partnership Managing Director Current
The Mpm Group Managing Director Current
The Mpm Group Founder Current
Centagenetix, Inc. Chairman Current
Omrix Biopharmaceuticals, Inc Director Current
The Convergence Guide Board of Directors Current
Xanodyne Pharmaceuticals, Inc. Board of Directors Current
Arriva Pharmaceuticals, Inc. Director Current
Genteric Inc. Director Current
PharmAthene, Inc. Director Current
Helicos BioSciences Corporation Director Current
The Convergence Forum Board of Directors Current
Whitehead Institute for Biomedical Research Board of Directors Current
Doubletwist Director Current
Pharmasset, Inc. Board of Directors Current
Radius Inc. Director Current
Elixir, LLC. Director Current
Cerimon Pharmaceuticals, Inc. Board of Directors Current
Radius Health Inc. Board of Directors Current
ViaCell, Inc. Director Current
Chiasma Inc. Board Member Current
Elixir Pharmaceuticals, Inc. Board of Directors Current
Bioexec Ventures, LLC Board of Directors Current
Whitehead Institute for Biomedical Research Member Current
The Boston Consulting Group, Inc. Mangement Position Former
Trans-Form Director Former
Idenix Pharmaceuticals Inc. Director Former
MPM Capital Limited Partnership General Partner Former

Organization Position Status
Omrix Biopharmaceuticals, Inc Board of Directors Current

Organization Position Status
Omrix Biopharmaceuticals, Inc Board of Directors Current

Organization Position Status
Omrix Biopharmaceuticals, Inc Board of Directors Current
GTC Biotherapeutics, Inc. Board of Directors Current
The Hartsdale Medical Group Board of Directors Current
Arthur D. Little, Inc. Chief Executive Officer Former
Arthur D. Little, Inc. Managing Director Former

Organization Position Status
Omrix Biopharmaceuticals, Inc Board of Directors Current
advertisement
IndustryTop Rated
advertisement
Click Here